Inventor · disambiguated record
Patrick Chaltin
Also filed as: CHALTIN PATRICK
13 granted patents·10 pending applications·45 citations·filing 2005–2024
88Inventor score
Top patents by PatentIndex Score
23 records- 0193US10117850B2Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseasesUNIV LEUVEN KATH·Filed 2016·Granted Nov 6, 2018·21 cites·19 claims
- 0290US12209081B2Heterocycle derivatives for treating TRPM3 mediated disordersUNIV LEUVEN KATH·Filed 2024·Granted Jan 28, 2025·3 cites·9 claims
- 0380US9266832B2Compounds for the treatment of neurodegenerative diseasesGRIFFIOEN GERARD·Filed 2011·Granted Feb 23, 2016·8 cites·14 claims
- 0478US8906906B2Viral replication inhibitorsCHALTIN PATRICK·Filed 2010·Granted Dec 9, 2014·4 cites·14 claims
- 0575US8618138B2Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseasesGRIFFIOEN GERARD·Filed 2010·Granted Dec 31, 2013·3 cites·18 claims
- 0672US8785638B2Thieno [2, 3-B] pyridine derivatives as viral replication inhibitorsBARDIOT DOROTHÉE·Filed 2010·Granted Jul 22, 2014·4 cites·9 claims
- 0769US9434722B2Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseasesUNIV LEUVEN KATH·Filed 2013·Granted Sep 6, 2016·1 cites·20 claims
- 0867US11939324B2Compounds for the treatment of epilepsy, neurodegenerative disorders and other CNS disordersREMYND N V·Filed 2022·Granted Mar 26, 2024·0 cites·12 claims
- 0967US9132129B2Antiviral compoundsCHALTIN PATRICK·Filed 2011·Granted Sep 15, 2015·1 cites·13 claims
- 1065US12404266B2Heterocycle derivatives for treating TRPM3 mediated disordersUNIV LEUVEN KATH·Filed 2021·Granted Sep 2, 2025·0 cites·13 claims
- 1158US2019054068A1Indole Amide Derivatives and Related Compounds for Use in the Treatment of Neurodegenerative DiseasesUNIV LEUVEN KATH·Filed 2018·Application pending·0 cites
- 1258US2025346605A1New derivatives for treating trpm3 mediated disordersUNIV LEUVEN KATH·Filed 2023·Application pending·0 cites
- 1358US2025346569A1New derivatives for treating trpm3 mediated disordersUNIV LEUVEN KATH·Filed 2023·Application pending·0 cites
- 1456US2015051195A1Novel viral replication inhibitorsUNIV LEUVEN KATH·Filed 2014·Application pending·0 cites
- 1552US2011224208A1Novel inhibitors of flavivirus replicationUNIV LEUVEN KATH·Filed 2009·Application pending·0 cites
- 1651US9499563B2Thieno [2, 3-B] pyridine derivatives as viral replication inhibitorsUNIV LEUVEN KATH·Filed 2014·Granted Nov 22, 2016·0 cites·18 claims
- 1751US2023391739A1Aryl derivatives for treating trpm3 mediated disordersUNIV LEUVEN KATH·Filed 2021·Application pending·0 cites
- 1850US11548881B2Compounds for the treatment of epilepsy, neurodegenerative disorders and other CNS disordersREMYND N V·Filed 2018·Granted Jan 10, 2023·0 cites·12 claims
- 1948US2015336965A1Novel antiviral compoundsUNIV LEUVEN KATH·Filed 2015·Application pending·0 cites
- 2039US2008199960A1Methods for the Delivery of Oligomeric CompoundsJULIANO RUDOLPH L·Filed 2005·Application pending·0 cites
- 2136US2012252801A1Antifungal compoundsBARDIOT DOROTHEE·Filed 2010·Application pending·0 cites
- 2234US9284271B2Compounds for the treatment of neurodegenerative diseasesGRIFFIOEN GERARD·Filed 2011·Granted Mar 15, 2016·0 cites·13 claims
- 2332US2012316161A1Novel antiviral compoundsCARLENS GUNTER·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Patrick Chaltin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →